ARCHIVES

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

This article is from The Cancer Letter archive.

Vol. 39 No. 28 | July 12, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975

For Frederick, Unseat Program Resources Inc.

March 3, 1995

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007